Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety

Florian Slimano,Amandine Baudouin,Jérémie Zerbit, Anne Toulemonde-Deldicque,Audrey Thomas-Schoemann,Régine Chevrier,Mikaël Daouphars,Isabelle Madelaine,Bertrand Pourroy, Jean-François Tournamille,Alain Astier,Florence Ranchon, Jean-Louis Cazin,Christophe Bardin,Catherine Rioufol

Cancer Treatment Reviews（2020）

引用 37|浏览30

暂无评分

摘要

•The COVID-19 pandemic causes unprecedented impact on cancer patients.•Cancer patients are greater susceptible to COVID-19 infection and intense symptoms.•A rethink of the care pathway is required to reduce the risk of contamination.•Oncologists must detect and manage drug-related problems with anti-COVID-19 drugs.•Caution is needed about interactions between anticancer and viral experimental drugs.

查看译文

关键词

COVID-19,Immune depression,Drug safety,Drug-drug interactions,Herb-Drug interactions,Drug-related problems,Clinical trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要